Multivariate analysis further confirmed that hepatic vein invasion, tumour multiplicity (multiple), history of T2D and PM of DPYSL3 remained the significant risk factors for reduced survival (Table 4). This evidence concerns the gene DPYSL3 and type 2 diabetes mellitus.